121 related articles for article (PubMed ID: 38521179)
1. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
[TBL] [Abstract][Full Text] [Related]
2. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
[TBL] [Abstract][Full Text] [Related]
3. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract][Full Text] [Related]
4. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
5. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
Liu Y; Ouyang L; Mao C; Chen Y; Li T; Liu N; Wang Z; Lai W; Zhou Y; Cao Y; Liu S; Liang Y; Wang M; Liu S; Chen L; Shi Y; Xiao D; Tao Y
Oncogene; 2022 Jul; 41(27):3570-3583. PubMed ID: 35688944
[TBL] [Abstract][Full Text] [Related]
6. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
8. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation.
Liu Z; Hu Q; Hu B; Cao K; Xu T; Hou T; Cao T; Wang R; Shi H; Zhang B
J Biol Chem; 2024 Jan; 300(1):105593. PubMed ID: 38145746
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury.
Wu Y; Jiao H; Yue Y; He K; Jin Y; Zhang J; Zhang J; Wei Y; Luo H; Hao Z; Zhao X; Xia Q; Zhong Q; Zhang J
Cell Death Differ; 2022 Sep; 29(9):1705-1718. PubMed ID: 35260822
[TBL] [Abstract][Full Text] [Related]
12. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
14. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation.
Xu Y; Zhang D; Ji J; Zhang L
Mol Carcinog; 2023 Jul; 62(7):1062-1072. PubMed ID: 37098835
[TBL] [Abstract][Full Text] [Related]
16. SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma.
Xie W; Shi L; Quan H; Xiao H; Chen J; Liu J; de Dieu Habimana J; Huang R; Luo J; Chen P; Li Z
Cell Oncol (Dordr); 2023 Oct; 46(5):1285-1299. PubMed ID: 37099251
[TBL] [Abstract][Full Text] [Related]
17. SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.
Hu L; Liu M; Chen L; Chan TH; Wang J; Huo KK; Zheng BJ; Xie D; Guan XY
Carcinogenesis; 2012 Aug; 33(8):1581-8. PubMed ID: 22570270
[TBL] [Abstract][Full Text] [Related]
18. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression.
Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z
Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993
[TBL] [Abstract][Full Text] [Related]
19. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
[TBL] [Abstract][Full Text] [Related]
20. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
[No Abstract] [Full Text] [Related]
[Next] [New Search]
